FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137606112> ?p ?o ?g. }

• W3137606112 abstract "Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a poor prognosis and limited treatment options. In recent years, chimeric antigen receptor (CAR) T cells have achieved remarkable success in the treatment of liquid malignancies but efficacy in solid malignancies is limited to date. A major hurdle is the lack of tumor specific targets. We aimed to address this issue in the case of PDAC by analyzing the expression of almost 400 cell-surface antigens on tumor cells of different patient derived xenograft (PDX) mouse models. Identified candidates were prioritized with respect to their off-tumor expression bioinformatically by using RNA and protein expression databases. The specificity of these target candidates was further validated on primary PDAC specimens using flow cytometry and a newly developed cyclic immunofluorescence (cyclic IF) microscopy technology. We identified Cutaneous Lymphocyte Antigen (CLA), CEACAM6 (CD66c), CDCP1 (CD318) and Tetraspanin-8 (TSPAN8) as having high specificity to tumor cells and restricted off-tumor expression. In addition, we investigated the expression of these targets using flow cytometry and cyclic IF microscopy on healthy tissue arrays. Target expression on healthy tissues was very restricted, which further underlined the quality of the novel target candidates. We generated CAR constructs differing in spacer length (XS, S, M, L) and scFv orientation (Vh-Vl, Vl-Vh) for each target candidate and thoroughly validated these CARs in co-culture assays that utilized cytotoxicity, activation marker expression and cytokine release as readouts. All CLA CARs were dysfunctional due to self-antigenicity on activated T cells. The most promising constructs for the other target candidates were evaluated in two pre-clinical PDAC mouse models. This revealed CD318 Vh-Vl XS, CD66c Vl-Vh XS and TSPAN8 Vh-Vl S as the most effective CAR constructs of the remaining targets. During CAR development we observed inferior in vivo functionality of long IgG-based spacers compared to their in vitro performance. It has been shown that these spacers convey unspecific binding in murine models. However, long spacers are regarded as beneficial when targeting membrane proximal epitopes. Thus, we evaluated a novel class of long spacers, derived from the SIGLEC family, with similar structural attributes as the IgG family but lack the natural unspecific binding sites. In non-solid and solid tumor settings, a novel SIGLEC-4 based spacer demonstrated superior functionality over long IgG spacers in vitro and in vivo with favorable activation marker expression and cytokine release for putative subsequent clinical applications. In summary, this project led to the identification of novel target candidates for PDAC and establishment of a set of highly functional targetspecific CARs that may pave the road for later clinical application and hopefully will help PDAC patients by establishing more efficient treatment options in the future." @default.
• W3137606112 created "2021-03-29" @default.
• W3137606112 creator A5048608844 @default.
• W3137606112 date "2022-02-21" @default.
• W3137606112 modified "2023-10-17" @default.
• W3137606112 title "Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates" @default.
• W3137606112 doi "https://doi.org/10.53846/goediss-8485" @default.
• W3137606112 hasPublicationYear "2022" @default.
• W3137606112 type Work @default.
• W3137606112 sameAs 3137606112 @default.
• W3137606112 citedByCount "0" @default.
• W3137606112 crossrefType "dissertation" @default.
• W3137606112 hasAuthorship W3137606112A5048608844 @default.
• W3137606112 hasBestOaLocation W31376061121 @default.
• W3137606112 hasConcept C147483822 @default.
• W3137606112 hasConcept C203014093 @default.
• W3137606112 hasConcept C2777701055 @default.
• W3137606112 hasConcept C502942594 @default.
• W3137606112 hasConcept C553184892 @default.
• W3137606112 hasConcept C86803240 @default.
• W3137606112 hasConcept C8891405 @default.
• W3137606112 hasConceptScore W3137606112C147483822 @default.
• W3137606112 hasConceptScore W3137606112C203014093 @default.
• W3137606112 hasConceptScore W3137606112C2777701055 @default.
• W3137606112 hasConceptScore W3137606112C502942594 @default.
• W3137606112 hasConceptScore W3137606112C553184892 @default.
• W3137606112 hasConceptScore W3137606112C86803240 @default.
• W3137606112 hasConceptScore W3137606112C8891405 @default.
• W3137606112 hasLocation W31376061121 @default.
• W3137606112 hasOpenAccess W3137606112 @default.
• W3137606112 hasPrimaryLocation W31376061121 @default.
• W3137606112 hasRelatedWork W10162477 @default.
• W3137606112 hasRelatedWork W12011916 @default.
• W3137606112 hasRelatedWork W1838470 @default.
• W3137606112 hasRelatedWork W19172956 @default.
• W3137606112 hasRelatedWork W23729165 @default.
• W3137606112 hasRelatedWork W25848639 @default.
• W3137606112 hasRelatedWork W28983714 @default.
• W3137606112 hasRelatedWork W29670928 @default.
• W3137606112 hasRelatedWork W31382826 @default.
• W3137606112 hasRelatedWork W33349234 @default.
• W3137606112 isParatext "false" @default.
• W3137606112 isRetracted "false" @default.
• W3137606112 magId "3137606112" @default.
• W3137606112 workType "dissertation" @default.